H.R. 4479 · 117th Congress · House

Facilitating Innovative Nuclear Diagnostics Act of 2021

Active· Referred to the Subcommittee on Health.
Introduced
Jul 16, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Facilitating Innovative Nuclear Diagnostics Act of 2021

This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2022 and as adjusted based on a specified fee schedule factor in each year thereafter.

Action Timeline

6
  1. JUL 19, 2021•Committee

    Referred to the Subcommittee on Health.

  2. JUL 16, 2021•IntroReferral

    Introduced in House

  3. JUL 16, 2021•IntroReferral

    Introduced in House

  4. JUL 16, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. JUL 16, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  6. JUL 16, 2021•Committee

    Referred to the Subcommittee on Health.

Committees

4

Health Subcommittee

hsif14

Referred: Jul 19, 2021

Active

Health Subcommittee

hswm02

Referred: Jul 16, 2021

Active

Ways and Means Committee

hswm00

Referred: Jul 16, 2021

Active

Energy and Commerce Committee

hsif00

Referred: Jul 16, 2021

Active